about
Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic moleculeMetallothioneins in the lung cancerCorrelation between levels of expression of minichromosome maintenance proteins, Ki-67 proliferation antigen and metallothionein I/II in laryngeal squamous cell cancerRole of metallothioneins in benign and malignant thyroid lesionsFunctional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disordersExpression of hypoxia-inducible factor-1α and vascular density in mammary adenomas and adenocarcinomas in bitches.Effects of synergistic massage and physical exercise on the expression of angiogenic markers in rat tendons.Expression of the MT1 melatonin receptor in ovarian cancer cells.Metallothionein 3 expression in normal skin and malignant skin lesions.Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression.Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues.The effect of physical training on the N-methyl-N-nitrosourea-induced mammary carcinogenesis of Sprague-Dawley ratsExpression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomasSignificance of podoplanin expression in cancer-associated fibroblasts: a comprehensive review.ACE and ACE2 expression in normal and malignant skin lesions.Expression of estrogen and progesterone receptors and Ki-67 antigen in Graves' disease and nodular goiter.The Molecular Effect of Diagnostic Absorbed Doses from 131I on Papillary Thyroid Cancer Cells In Vitro.Expression of Cell Cycle-related Proteins p16, p27 and Ki-67 Proliferating Marker in Laryngeal Squamous Cell Carcinomas and in Laryngeal Papillomas.Metallothioneins in Normal and Cancer Cells.Expression of metallothionein 3 in ductal breast cancer.Classical and atypical resistance of cancer cells as a target for resveratrol.Prognostic significance of SOX18 expression in non-small cell lung cancer.Current Treatment of Chronic Lymphocytic Leukemia.Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.The Effect of Diagnostic Absorbed Doses from 131I on Human Thyrocytes in Vitro.Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease.Correlation of Pyruvate Kinase M2 Expression with Clinicopathological Data in Ovarian Cancer.Role of the Lymphatic System in the Pathogenesis of Hypertension in Humans.Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions.Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer.A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia.Microenvironment-induced PIM kinases promote CXCR4-triggered mTOR pathway required for chronic lymphocytic leukaemia cell migration.Side to side coaptation--new technic in peripherial nerve surgery--preliminary report.Increased expression of E3 ubiquitin ligases targeting p53 in CLL patients with wild-type TP53 exhibits associations with clinical features of the disease.Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.The rabbit brachial plexus as a model for nerve repair surgery--histomorphometric analysisExpression of metallothioneins I and II in kidney of doxorubicin-treated ratsMorphological and immunohistological characteristics of follicular-compact thyroid carcinoma in dogMetallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients
P50
Q27335599-33B2C0C3-9685-4F12-A75B-9889DF49583EQ28082163-9937F572-ABA4-4B94-8212-06BE2AE4EAA6Q28270789-7FE27E12-F346-41BD-9C79-661553B27B71Q28393061-03D26276-FCCA-4A54-97B4-BF246E25CD13Q28740884-00F3AA9F-304F-49FC-A098-A0963D74280FQ33591698-177F1188-A16E-4114-A0EB-C37595A35F6DQ33679182-64C67A4F-3543-439E-B425-230F4BC07879Q34835245-087AAD30-F585-4128-B2A7-7CB33A7ED9BAQ34877319-A3021652-9A0A-42FD-AA1C-AF3CB77E254FQ35561233-78E1D97B-FDCE-44FC-A5B5-504AC944DD61Q35929411-3E13A139-0C71-4DEC-814A-F49ACA63B4E8Q37071208-88198917-CA33-416E-93DB-465D1FBD69A8Q37145151-3B647986-A6C3-46F9-ADC8-95F2113A94E9Q38099246-29222556-C5D0-4152-BE82-C059C331B7B7Q38394305-B3230257-CC6B-4366-9FC1-D3380B1B96D0Q38395448-5F646A17-FDE7-416C-B3B0-50EAE82E6088Q38700292-7C7C0619-7754-43CF-B78F-977AF5DF8F00Q38704588-4D6C733B-3F2E-433E-B3CC-4336376D8DD9Q38723681-44F28BF6-8C57-483B-AF5C-DBF41E74CBACQ38731339-B5DF10DE-3B50-42B6-8658-FF265C67DF3EQ38757233-63E7A8BE-8B4B-482F-9FF6-1B0093CE7C3DQ38948505-1A3EC9D5-F011-404C-8018-003737D6D801Q39129372-A3A0F176-7F60-45F9-884F-B7CF45BD66D6Q41721818-C2BA658B-D44A-4A01-A68B-B810DD1D6BBCQ42407359-85E969CE-ADED-4AC1-A48C-1315E7944136Q43182273-54773D82-33E0-4BFB-9CA7-04C5AE5BAD33Q47249438-63A28A11-2732-4FDD-B239-4FA7EE16686EQ47561234-589EC5EF-207B-48AB-AAC7-E739BFD5E989Q47857786-FF200287-FD35-4180-A5BE-9F0A9B99C476Q50933938-1307149B-E671-49B6-B12E-5764656779BEQ52571251-CA2FB357-8A3F-4842-9406-4E6A197105EEQ52582842-BDE68DB9-05AD-43CC-9E98-48CB201FFD84Q53118562-141247BB-4A4D-4D82-BE3C-FE192539AC3AQ53329470-F9CEA9DA-600B-490F-A6E9-438F0EA62EA4Q54242111-86052667-D2BB-47B5-86C4-DD479A526866Q54312855-9C552A35-427F-4D58-94FD-0CA2F5EE572DQ85682272-AB38516F-4568-42FB-AF8E-C42F4B778CA5Q86802228-000991BC-B67F-4505-9E9A-3C389DF46FD6Q87372803-0DB0B6A5-F7D9-4E6C-AECB-011691AFCAF2Q87440481-57073D61-7AF3-42EC-8928-D7B865C685CC
P50
description
Pools onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Bartosz Pula
@ast
Bartosz Pula
@en
Bartosz Pula
@es
Bartosz Pula
@nl
Bartosz Puła
@ca
Bartosz Puła
@cs
Bartosz Puła
@gl
Bartosz Puła
@hr
Bartosz Puła
@hsb
Bartosz Puła
@it
type
label
Bartosz Pula
@ast
Bartosz Pula
@en
Bartosz Pula
@es
Bartosz Pula
@nl
Bartosz Puła
@ca
Bartosz Puła
@cs
Bartosz Puła
@gl
Bartosz Puła
@hr
Bartosz Puła
@hsb
Bartosz Puła
@it
prefLabel
Bartosz Pula
@ast
Bartosz Pula
@en
Bartosz Pula
@es
Bartosz Pula
@nl
Bartosz Puła
@ca
Bartosz Puła
@cs
Bartosz Puła
@gl
Bartosz Puła
@hr
Bartosz Puła
@hsb
Bartosz Puła
@it
P106
P1153
36681376200
P1412
P1559
Bartosz Puła
@pl
P21
P214
58146284291915330614
P27
P31
P496
0000-0003-0116-5002